Continuous Glucose Monitoring in Diabetes Care in Saudi Arabia: Addressing Performance Standards and Regulatory Gaps—Literature Review and Consensus Report
The resulting recommendations advocate for aligning Saudi regulatory standards with international frameworks like Food and Drug Administration iCGM criteria, Medical Device Regulation (MDR)-aligned criteria, establishing and enforcing minimum performance criteria, including dynamic testing for glucose fluctuations, strengthening local post-market surveillance capacity, mandating transparent data reporting by manufacturers, and facilitating comprehensive clinical education and cross-sector collaboration.
Authors
- Lamya Alzubaidi (ORCID: https://orcid.org/0009-0007-1516-7304)
- Saad Alzahrani (ORCID: https://orcid.org/0000-0002-5516-7807)
- MOHAMMED AL-SOFIANI
- Naweed Alzaman (ORCID: https://orcid.org/0000-0002-1543-1132)
- Mohammed Almehthel (ORCID: https://orcid.org/0000-0002-4031-881X)
- Saud Alsifri
- Metib Alotaibi (ORCID: https://orcid.org/0000-0002-2051-8558)
- Raed Aldahash
- Emad Roushdy Issak
- Fahad Alsabaan
- Hussein Elbadawi
- Mohammed Aldawish
- Mohammed Alowairdhi
Institutions
- Riyadh Armed Forces Hospital (SA)
- King Saud bin Abdulaziz University for Health Sciences (SA)
- Taibah University (SA)
- King Fahd Medical City (SA)
- King Saud University (SA)
- Saudi Center for Organ Transplantation (SA)
- Armed Forces Hospital (SA)
- Ministry of Health (SA)
- Security Forces Hospital (SA)
- Egyptian American Medical Center (EG)
Publication Details
- Journal
- Journal of Diabetes Science and Technology
- Published
- 2026-02-16
- DOI
- https://doi.org/10.1177/19322968261422250
- Primary Topic
- Diabetes Management and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00